Medicines in ATC group L — Antineoplastic and immunomodulating agents
Overview of medicines in ATC class L (Antineoplastic and immunomodulating agents) and their availability in Belgian pharmacies.
1857 medicines
- Tacni 0,5 mg
- Tacni 1 mg
- Tacni 1 mg
- Tacni 5 mg
- Tacni 5 mg
- Tafinlar 50 mg — dabrafenib
- Tafinlar 50 mg — dabrafenib
- Tafinlar 75 mg — dabrafenib
- Tafinlar 75 mg — dabrafenib
- Tafinlar 75 mg — dabrafenib
- Tafinlar 75 mg — dabrafenib
- Tagrisso 40 mg — osimertinib
- Tagrisso 40 mg — osimertinib
- Tagrisso 80 mg — osimertinib
- Tagrisso 80 mg — osimertinib
- Taltz 80 mg — ixekizumab
- Taltz 80 mg — ixekizumab
- Talvey 2 mg/ml — talquetamab
- Talvey 40 mg/ml — talquetamab
- Talzenna 0.1 mg — talazoparib
- Talzenna 0.25 mg — talazoparib
- Talzenna 1 mg — talazoparib
- Tamizam 20 mg
- Tamizam 20 mg
- Tamoplex 10 mg
- Tamoplex 20 mg — tamoxifen
- Tamoxifen Mylan 20 mg
- Tamoxifen Sandoz 20 mg — tamoxifen
- Tamoxifen Sandoz 20 mg — tamoxifen
- Tarceva 100 mg
- Tarceva 150 mg — erlotinib
- Tarceva 150 mg — erlotinib
- Targretin 75 mg — bexaroteen
- Tasigna 150 mg — nilotinib
- Tasigna 200 mg — nilotinib
- Tasigna 50 mg — nilotinib
- Taxotere 160 mg/8 ml — docetaxel
- Taxotere 20 mg/1 ml — docetaxel
- Taxotere 80 mg/4 ml — docetaxel
- Tecartus 0.4 10*8 cells/ml - 2 10*8 cells/ml — brexucabtagene autoleucel
- Tecentriq 1200 mg — atezolizumab
- Tecentriq 1200 mg — atezolizumab
- Tecentriq 1875 mg — atezolizumab
- Tecentriq 840 mg — atezolizumab
- Tecentriq 840 mg — atezolizumab
- Tecfidera 120 mg — dimethylfumaraat
- Tecfidera 120 mg — dimethylfumaraat
- Tecfidera 240 mg — dimethylfumaraat
- Tecfidera 240 mg — dimethylfumaraat
- Tecfidera 240 mg — dimethylfumaraat
- Tecfidera 240 mg — dimethylfumaraat
- Tecvayli 10 mg/ml — teclistamab
- Tecvayli 90 mg/ml — teclistamab
- Temodal 100 mg — temozolomide
- Temodal 140 mg — temozolomide
- Temodal 180 mg
- Temodal 2.5 mg/ml
- Temodal 20 mg — temozolomide
- Temodal 20 mg — temozolomide
- Temodal 250 mg — temozolomide